Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0000935836-25-000552

Director sold 20,221 shares at $4.06 ($82,097)

From the SEC's structured data for this filing

Trades in this filing

Hively Brad · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-08-19 Sale : show line 1 in the form −20,221 $4.06 $82,097 622,980 D
Open-market sales · 20,221 sh · avg $4.06 · $82,097
Loading xslF345X05/ownership.xml…